487 related articles for article (PubMed ID: 15181099)
1. Non-acylated ghrelin counteracts the metabolic but not the neuroendocrine response to acylated ghrelin in humans.
Broglio F; Gottero C; Prodam F; Gauna C; Muccioli G; Papotti M; Abribat T; Van Der Lely AJ; Ghigo E
J Clin Endocrinol Metab; 2004 Jun; 89(6):3062-5. PubMed ID: 15181099
[TBL] [Abstract][Full Text] [Related]
2. Non-acylated ghrelin does not possess the pituitaric and pancreatic endocrine activity of acylated ghrelin in humans.
Broglio F; Benso A; Gottero C; Prodam F; Gauna C; Filtri L; Arvat E; van der Lely AJ; Deghenghi R; Ghigo E
J Endocrinol Invest; 2003 Mar; 26(3):192-6. PubMed ID: 12809167
[TBL] [Abstract][Full Text] [Related]
3. Acetylcholine does not play a major role in mediating the endocrine responses to ghrelin, a natural ligand of the GH secretagogue receptor, in humans.
Broglio F; Gottero C; Benso A; Prodam F; Casanueva FF; Dieguez C; van der Lely AJ; Deghenghi R; Arvat E; Ghigo E
Clin Endocrinol (Oxf); 2003 Jan; 58(1):92-8. PubMed ID: 12519418
[TBL] [Abstract][Full Text] [Related]
4. d-Lys-GHRP-6 does not modify the endocrine response to acylated ghrelin or hexarelin in humans.
Benso A; Prodam F; Lucatello B; Gramaglia E; Riganti F; Schneider H; van der Lely AJ; Muccioli G; Ghigo E; Broglio F
Neuropeptides; 2007 Feb; 41(1):45-9. PubMed ID: 17112585
[TBL] [Abstract][Full Text] [Related]
5. Endocrine activities of ghrelin, a natural growth hormone secretagogue (GHS), in humans: comparison and interactions with hexarelin, a nonnatural peptidyl GHS, and GH-releasing hormone.
Arvat E; Maccario M; Di Vito L; Broglio F; Benso A; Gottero C; Papotti M; Muccioli G; Dieguez C; Casanueva FF; Deghenghi R; Camanni F; Ghigo E
J Clin Endocrinol Metab; 2001 Mar; 86(3):1169-74. PubMed ID: 11238504
[TBL] [Abstract][Full Text] [Related]
6. The endocrine response to acute ghrelin administration is blunted in patients with anorexia nervosa, a ghrelin hypersecretory state.
Broglio F; Gianotti L; Destefanis S; Fassino S; Abbate Daga G; Mondelli V; Lanfranco F; Gottero C; Gauna C; Hofland L; Van der Lely AJ; Ghigo E
Clin Endocrinol (Oxf); 2004 May; 60(5):592-9. PubMed ID: 15104562
[TBL] [Abstract][Full Text] [Related]
7. Cortistatin-8, a synthetic cortistatin-derived ghrelin receptor ligand, does not modify the endocrine responses to acylated ghrelin or hexarelin in humans.
Prodam F; Benso A; Gramaglia E; Lucatello B; Riganti F; van der Lely AJ; Deghenghi R; Muccioli G; Ghigo E; Broglio F
Neuropeptides; 2008 Feb; 42(1):89-93. PubMed ID: 18061663
[TBL] [Abstract][Full Text] [Related]
8. Unacylated ghrelin is active on the INS-1E rat insulinoma cell line independently of the growth hormone secretagogue receptor type 1a and the corticotropin releasing factor 2 receptor.
Gauna C; Delhanty PJ; van Aken MO; Janssen JA; Themmen AP; Hofland LJ; Culler M; Broglio F; Ghigo E; van der Lely AJ
Mol Cell Endocrinol; 2006 Jun; 251(1-2):103-11. PubMed ID: 16647196
[TBL] [Abstract][Full Text] [Related]
9. Ghrelin does not mediate the somatotroph and corticotroph responses to the stimulatory effect of glucagon or insulin-induced hypoglycaemia in humans.
Broglio F; Prodam F; Gottero C; Destefanis S; Me E; Riganti F; Giordano R; Picu A; Balbo M; Van der Lely AJ; Ghigo E; Arvat E
Clin Endocrinol (Oxf); 2004 Jun; 60(6):699-704. PubMed ID: 15163333
[TBL] [Abstract][Full Text] [Related]
10. Endocrine responses to ghrelin in adult patients with isolated childhood-onset growth hormone deficiency.
Aimaretti G; Baffoni C; Broglio F; Janssen JA; Corneli G; Deghenghi R; van der Lely AJ; Ghigo E; Arvat E
Clin Endocrinol (Oxf); 2002 Jun; 56(6):765-71. PubMed ID: 12072046
[TBL] [Abstract][Full Text] [Related]
11. Neuroendocrine and metabolic effects of acute ghrelin administration in human obesity.
Tassone F; Broglio F; Destefanis S; Rovere S; Benso A; Gottero C; Prodam F; Rossetto R; Gauna C; van der Lely AJ; Ghigo E; Maccario M
J Clin Endocrinol Metab; 2003 Nov; 88(11):5478-83. PubMed ID: 14602793
[TBL] [Abstract][Full Text] [Related]
12. Endocrine activities of cortistatin-14 and its interaction with GHRH and ghrelin in humans.
Broglio F; Arvat E; Benso A; Gottero C; Prodam F; Grottoli S; Papotti M; Muccioli G; van der Lely AJ; Deghenghi R; Ghigo E
J Clin Endocrinol Metab; 2002 Aug; 87(8):3783-90. PubMed ID: 12161511
[TBL] [Abstract][Full Text] [Related]
13. Ghrelin stimulates, whereas des-octanoyl ghrelin inhibits, glucose output by primary hepatocytes.
Gauna C; Delhanty PJ; Hofland LJ; Janssen JA; Broglio F; Ross RJ; Ghigo E; van der Lely AJ
J Clin Endocrinol Metab; 2005 Feb; 90(2):1055-60. PubMed ID: 15536157
[TBL] [Abstract][Full Text] [Related]
14. Effects of acute administration of acylated and unacylated ghrelin on glucose and insulin concentrations in morbidly obese subjects without overt diabetes.
Kiewiet RM; van Aken MO; van der Weerd K; Uitterlinden P; Themmen AP; Hofland LJ; de Rijke YB; Delhanty PJ; Ghigo E; Abribat T; van der Lely AJ
Eur J Endocrinol; 2009 Oct; 161(4):567-73. PubMed ID: 19628651
[TBL] [Abstract][Full Text] [Related]
15. The GH-releasing effect of ghrelin, a natural GH secretagogue, is only blunted by the infusion of exogenous somatostatin in humans.
Di Vito L; Broglio F; Benso A; Gottero C; Prodam F; Papotti M; Muccioli G; Dieguez C; Casanueva FF; Deghenghi R; Ghigo E; Arvat E
Clin Endocrinol (Oxf); 2002 May; 56(5):643-8. PubMed ID: 12030916
[TBL] [Abstract][Full Text] [Related]
16. In vitro and in vivo effect of acylated and unacylated ghrelin on neonatal glucose homeostasis.
Ni H; De Waele K; Walia P; Chanoine JP
Pediatr Res; 2010 Jun; 67(6):609-13. PubMed ID: 20496472
[TBL] [Abstract][Full Text] [Related]
17. Unraveling the role of the ghrelin gene peptides in the endocrine pancreas.
Granata R; Baragli A; Settanni F; Scarlatti F; Ghigo E
J Mol Endocrinol; 2010 Sep; 45(3):107-18. PubMed ID: 20595321
[TBL] [Abstract][Full Text] [Related]
18. Somatostatin, cortistatin, ghrelin and glucose metabolism.
Gauna C; van der Lely AJ
J Endocrinol Invest; 2005; 28(11 Suppl International):127-31. PubMed ID: 16625861
[TBL] [Abstract][Full Text] [Related]
19. Hormonal and metabolic responses to acute ghrelin administration in patients with bulimia nervosa.
Fassino S; Daga GA; Mondelli V; Pierò A; Broglio F; Picu A; Giordano R; Baldi M; Arvat E; Ghigo E; Gianotti L
Psychoneuroendocrinology; 2005 Jul; 30(6):534-40. PubMed ID: 15808922
[TBL] [Abstract][Full Text] [Related]
20. Ghrelin: endocrine, metabolic and cardiovascular actions.
Broglio F; Prodam F; Me E; Riganti F; Lucatello B; Granata R; Benso A; Muccioli G; Ghigo E
J Endocrinol Invest; 2005; 28(5 Suppl):23-5. PubMed ID: 16114271
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
